Daniel D. Myers, DVM, MPH, Angela E. Hawley, MS, Diana M

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

Clinical Outcomes After Varicose Vein Procedures in Octogenarians Within the Vascular Quality Initiative Varicose Vein Registry (VQI VVR) Danielle C.

Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator E.A Henao, MD, W.Todd.

Vein wall re-endothelialization after deep vein thrombosis is improved with low- molecular-weight heparin Daria K. Moaveni, MD, Erin M. Lynch, MS, Cathy.

Yi-kuan Chen, MD, Xue-mei Jiang, MSc, Jian-ping Gong, MD

National trends in venous disease

Masson's vegetant intravascular hemangioendothelioma in an external jugular vein aneurysm with recurrent thrombosis Majdi El Husseiny, MD, Nicole Benhaiem,

Osama M. El-Sayed, BS, Nicholas A. Dewyer, MD, Catherine E

Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers William Marston, MD, Daniel Fish,

Daniel L. Davenport, PhD, Eleftherios S

Daniel L. Davenport, PhD, Eleftherios S

Deep axial reflux, an important contributor to skin changes or ulcer in chronic venous disease Gudmundur Danielsson, MD, PhD, Bo Eklof, MD, PhD, Andrew.

Jeanwan Kang, MD, Hassan Albadawi, MD, Virendra I. Patel, MD, Thomas A

Postthrombotic vein wall remodeling: Preliminary observations

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Pylephlebitis and acute mesenteric ischemia in a young man with inherited thrombophilia and suspected foodborne illness Sarah P. Pradka, MD, Christine.

The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling Kristopher B.

Thrombolysis for deep venous thrombosis

Thomas W. Wakefield, MD, Robert M

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD

Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis Jose A. Diaz, MD, Nicole E. Ballard-Lipka, BS,

Subclavian venous aneurysm: Case report and review of the literature

Monocyte recruitment in venous thrombus resolution

Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot.

Manu R. Varma, BS, Daria M. Moaveni, BS, Nicholas A. Dewyer, Andrea J

Primary tibial vein aneurysm with recurrent pulmonary emboli

Luigi Pascarella, MD, Geert W. Schmid-Schönbein, PhD, John Bergan, MD

The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis Joe F. Baldwin,

Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal Alphonse DeLucia, MD, Thomas W.

L. J. Downing, MD, T. W. Wakefield, MD, R. M. Strieter, MD, M. R

Circulating inflammatory cells are associated with vein graft stenosis

Carotid artery replacement in conjunction with resection of squamous cell carcinoma of the neck: Preliminary results M.Kathleen Reilly, PhD, MD, Malcolm.

Gene expression changes evoked in a venous segment exposed to arterial flow Deborah Abeles, MD, Stephanie Kwei, MD, George Stavrakis, MS, Yuzhi Zhang,

Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis Daniel.

Brachiocephalic venous aneurysm with unusual clinical observations

Bao-Ngoc Nguyen, MD, Richard F

Limited B-mode venous imaging versus complete color-flow duplex venous scanning for detection of proximal deep venous thrombosis Roberta Poppiti, BS,

Analysis of 30-day readmission after aortoiliac and infrainguinal revascularization using the American College of Surgeons National Surgical Quality Improvement.

Sequestration of platelets in the pulmonary circulation as a consequence of protamine reversal of the anticoagulant effects of heparin Thomas W. Wakefield,

“Bull's-eye” sign on gadolinium-enhanced magnetic resonance venography determines thrombus presence and age: A preliminary study James B. Froehlich,

Refinements in the ultrasonic detection of popliteal vein reflux

Julia Humphries, MSc, Catharine L

A case of chest wall angiosarcoma associated with breast implants

The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus Andrew D.R. Northeast, MA, FRCS, Kenneth.

Neutropenia impairs venous thrombosis resolution in the rat

Unusual venous thrombosis associated with protein C deficiency

Reviewer Acknowledgment

Treatment of venous disease – The innovators

A. N. Nicolaides, MS, FRCS, M. K. Hussein, MD, FRCS, G. Szendro, MD, D

Femoral vein valvuloplasty: Intraoperative angioscopic evaluation and hemodynamic improvement Harold J. Welch, MD, Robert L. McLaughlin, RVT, Thomas.

Deep vein obstruction and leg swelling caused by femoral ganglion

Mesenteric venous thrombosis

Prevention of air travel–related deep venous thrombosis with mechanical devices: Active foot movements produce similar hemodynamic effects Fedor Lurie,

Regarding “Venous ulcers and the superficial venous system”

Renal failure after embolization of a prosthetic mitral valve disc and review of systemic disc embolization Thomas H. Schwarcz, M.D., Laurence H. Coffin,

Arie Markel, MD, Richard A. Manzo, BS, CCVT, Robert O. Bergelin, MS, D

Renal cell carcinoma with inferior vena caval involvement

Molecular characterization of post-thrombotic syndrome

FT04. “The Vein Is Screwed” Proof of Concept of the VeinScrew: A New Percutaneous Venous Closure Device Doeke Boersma, MD, Frans Moll, MD, PhD, Gert Jan.

Blunt traumatic iliac vein laceration without pelvic fracture: A rare entity Bernard Boulanger, MD, FRCS(C), John Green, DO, Aurelio Rodriguez, MD, FACS

Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R

Signs and symptoms of saphenous nerve injury after greater saphenous vein stripping: prevalence, severity, and relevance for modern practice Charles.

Aditya Agrawal, MS, FRCS, Richard Whitehouse, MD, FRCS, Robert W

William C. Krupski, MD. , Arie Bass, MD, Ralph B. Dilley, MD, Eugene F

Decreased venous thrombosis with an oral inhibitor of P selectin

The structure and processes of the Pacific Vascular Symposium 6

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Open repair of abdominal aortic aneurysm in a centenarian

Andres Schanzer, BA, Caron B. Rockman, MD, Glenn R

Gene expression changes evoked in a venous segment exposed to arterial flow Deborah Abeles, MD, Stephanie Kwei, MD, George Stavrakis, MS, Yuzhi Zhang,

Presentation transcript:

P-selectin and leukocyte microparticles are associated with venous thrombogenesis Daniel D. Myers, DVM, MPH, Angela E. Hawley, MS, Diana M. Farris, LVT, Shirley K. Wrobleski, BS, Porama Thanaporn, BSE, Robert G. Schaub, PhD, Denisa D. Wagner, PhD, Anjali Kumar, PhD, Thomas W. Wakefield, MD Journal of Vascular Surgery Volume 38, Issue 5, Pages 1075-1089 (November 2003) DOI: 10.1016/S0741-5214(03)01033-4

Fig 1 Experimental protocol. WT, Wild type; ^CT, mice with high circulating levels of soluble P-selectin; PKO, P-selectin gene-deleted mice; EPKO, double gene-deleted mice. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 2 Thrombus mass at day 2 and day 6 in shams, wild type mice (WT), mice with high circulating levels of soluble P-selectin (^CT) mice, P-selectin gene-deleted mice (PKO), and double gene-deleted mice (EPKO). Shams included WT, ^CT, and PKO groups. n, Number of animals per group. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 3 Morphometric evaluation of inflammatory cells in the vein wall at day 2 and day 6 in shams, wild type (WT) mice, mice with high circulating levels of soluble P-selectin (^CT) mice, P-selectin gene-deleted mice (PKO), and double gene-deleted mice (EPKO). Shams included WT, ^CT, and PKO groups. n, Number of animals per group; neut, neutrophils; mono, monocytes; TC, total inflammatory cells. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 4 Fluorescence-activated cell scanning analysis with negative controls located on the left, and study specimens on the right. Shown is a representative example of each group at day 2 (A) and day 6 (B) in wild type (WT) mice, mice with high circulating levels of soluble P-selectin (^CT) mice, P-selectin gene-deleted mice (PKO), and double gene-deleted mice (EPKO). Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 4 Fluorescence-activated cell scanning analysis with negative controls located on the left, and study specimens on the right. Shown is a representative example of each group at day 2 (A) and day 6 (B) in wild type (WT) mice, mice with high circulating levels of soluble P-selectin (^CT) mice, P-selectin gene-deleted mice (PKO), and double gene-deleted mice (EPKO). Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 5 Soluble P-selectin levels at day 2 and day 6 in sham mice, wild type (WT) mice, mice with high circulating levels of soluble P-selectin (^CT) mice, P-selectin gene-deleted mice (PKO), and double gene-deleted mice (EPKO). Shams at day 2 include WT (6.01 ng/mg), ^CT (27.6 ng/mg), and PKO (0 ng/mg); shams at day 6 include WT (7.8 ng/mg), ^CT (27.2 ng/mg), and PKO (0 ng/mg). n, Number of animals per group. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 6 Soluble E-selectin levels at day 2 and day 6 in sham mice, wild type (WT) mice, mice with high circulating levels of soluble P-selectin (^CT) mice, P-selectin gene-deleted mice (PKO), and double gene-deleted mice (EPKO). Shams at day 2 include WT (1284 pg/mg), ^CT (1023 pg/mg), and PKO (567 pg/mg); shams at day 6 include WT (1688 pg/mg), ^CT (1189 pg/mg), and PKO (615 pg/mg). n, Number of animals per group. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 7 Thrombus mass analysis at day 2 and day 6 in wild type mice (WT), mice with high circulating levels of soluble P-selectin (^CT), ^CT + rPSGL-Ig mice, ^CT + Ab-PSGL-1 mice, WT + P-selectin (Psel) mice, and WT + P-selectin + rPSGL-Ig mice. WT + P-selectin mice had a 15% increase in thrombus mass above WT mice at day 2 and a 21% increase in TM above WT mice at day 6. n, Number of animals per group. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 8 Fluorescence-activated cell scanning analysis with negative controls located on the left and study specimens on the right. Shown is a representative example of each group at day 2 (A) and day 6 (B) in ^CT + rPSGL-Ig, ^CT + Ab-PSGL-1 mice, WT + P-selectin, and WT + P-selectin + rPSGL-Ig. ^CT, Mice with high circulating levels of soluble P-selectin; WT, wild type. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)

Fig 8 Fluorescence-activated cell scanning analysis with negative controls located on the left and study specimens on the right. Shown is a representative example of each group at day 2 (A) and day 6 (B) in ^CT + rPSGL-Ig, ^CT + Ab-PSGL-1 mice, WT + P-selectin, and WT + P-selectin + rPSGL-Ig. ^CT, Mice with high circulating levels of soluble P-selectin; WT, wild type. Journal of Vascular Surgery 2003 38, 1075-1089DOI: (10.1016/S0741-5214(03)01033-4)